Diabex: Exercise Training Intervention in Children With Type 1 Diabetes

Sponsor
University Hospital, Geneva (Other)
Overall Status
Completed
CT.gov ID
NCT01220479
Collaborator
Swiss National Science Foundation (Other)
59
1
4
93
0.6

Study Details

Study Description

Brief Summary

Type 1 diabetes mellitus (T1DM) is associated with multiple co-morbidities, such as hypertension, dyslipidemia, coronary heart disease and osteoporosis. The foundation of these conditions lays in childhood. Exercise is known to have a positive influence on bone mineral density (BMD) and some impact on cardiovascular disease risk factors in healthy children, but little is known about these associations in children with T1DM.

The main purpose of this study is to assess the effects of a 9-month weight-bearing exercise training program on skeletal development in children with T1DM, compared to healthy subjects. The second aim is to evaluate whether the program influences also cardiovascular diseases risk factors.

This is a randomized controlled study incorporating 30 children with T1DM and 30 healthy children. Both groups are randomly divided (1:1) in an exercise or a control group: 1) exercise diabetic, 2) controls diabetic, 3) exercise healthy, 4) controls healthy.

Exercise groups participate to an identical weight-bearing exercise training program 2 x 90 minutes per week and controls are relatively inactive.

Main measures include: total body, lumbar spine and hip BMD by DXA, body fat and fat-free mass, bone biomarkers levels, resting and ambulatory blood pressure and fasting blood lipids.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Exercise training program
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
59 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Impact of an Exercise Training Program on Bone Development and Cardiovascular Disease Risk Factors in Children With Type 1 Diabetes Mellitus
Study Start Date :
Sep 1, 2001
Actual Primary Completion Date :
Dec 1, 2008
Actual Study Completion Date :
Jun 1, 2009

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control Healthy

Behavioral: Exercise training program
Exercise Diabetic and Healthy groups perform a similar training program including two exercise sessions per week, of 90 minutes each, during 9 months (excluding holidays) under supervision by physical education teachers and pediatricians. Sessions comprise various weight-bearing activities: rope skipping, jumping, ball games and gymnastics. Control groups are relatively inactive.

No Intervention: Control Diabetic

Behavioral: Exercise training program
Exercise Diabetic and Healthy groups perform a similar training program including two exercise sessions per week, of 90 minutes each, during 9 months (excluding holidays) under supervision by physical education teachers and pediatricians. Sessions comprise various weight-bearing activities: rope skipping, jumping, ball games and gymnastics. Control groups are relatively inactive.

Experimental: Exercise Diabetic

Behavioral: Exercise training program
Exercise Diabetic and Healthy groups perform a similar training program including two exercise sessions per week, of 90 minutes each, during 9 months (excluding holidays) under supervision by physical education teachers and pediatricians. Sessions comprise various weight-bearing activities: rope skipping, jumping, ball games and gymnastics. Control groups are relatively inactive.

Experimental: Exercise Healthy

Behavioral: Exercise training program
Exercise Diabetic and Healthy groups perform a similar training program including two exercise sessions per week, of 90 minutes each, during 9 months (excluding holidays) under supervision by physical education teachers and pediatricians. Sessions comprise various weight-bearing activities: rope skipping, jumping, ball games and gymnastics. Control groups are relatively inactive.

Outcome Measures

Primary Outcome Measures

  1. Bone mineral density and content [Baseline]

    Assessment of bone mineral density (BMD) and content (BMC) at the whole body, hip and lumbar spine using DXA.

  2. Bone mineral density and content [at 9 months]

    Assessment of bone mineral density (BMD) and content (BMC) at the whole body, hip and lumbar spine using DXA.

Secondary Outcome Measures

  1. Anthropometrics [Baseline]

    Body weight, height, body mass index and pubertal stage

  2. Blood lipids levels [Baseline]

    Fasting total cholesterol, LDL-Cholesterol, HDL-Cholesterol, triglycerides, lipoprotein (a), apolipoproteins A-I and B levels.

  3. Physical activity [Baseline]

    Physical activity level by questionnaire and accelerometer

  4. Nutrition [Baseline]

    Total energy, proteins, lipids, carbohydrates and calcium intakes using food records

  5. Circulating bone biomarkers levels [Baseline]

    Serum levels of beta-CrossLaps (CTX), N-MID-Osteocalcin (OC), N-Terminal Propeptide of Type I Collagen (PINP) and 25-OH-vitamin D (25-OH-D)

  6. Glycated Haemoglobin [Baseline]

    capillary HbA1c levels

  7. Systemic blood pressure [Baseline]

    Resting and 24-hour ambulatory systemic blood pressure monitoring

  8. Body composition [Baseline]

    Assessment of whole body and abdominal fat mass, and total fat-free mass using DXA.

  9. Anthropometrics [at 9 months]

    Body weight, height, body mass index and pubertal stage

  10. Blood lipids levels [at 9 months]

    Fasting total cholesterol, LDL-Cholesterol, HDL-Cholesterol, triglycerides, lipoprotein (a), apolipoproteins A-I and B levels.

  11. Physical activity [at 9 months]

    Physical activity level by questionnaire and accelerometer

  12. Nutrition [at 9 months]

    Total energy, proteins, lipids, carbohydrates and calcium intakes using food records

  13. Circulating bone biomarkers levels [at 9 months]

    Serum levels of beta-CrossLaps (CTX), N-MID-Osteocalcin (OC), N-Terminal Propeptide of Type I Collagen (PINP) and 25-OH-vitamin D (25-OH-D)

  14. Glycated Haemoglobin [at 3 months]

    capillary HbA1c levels

  15. Glycated Haemoglobin [at 6 months]

    capillary HbA1c levels

  16. Glycated Haemoglobin [at 9 months]

    capillary HbA1c levels

  17. Systemic blood pressure [at 9 months]

    Resting and 24-hour ambulatory systemic blood pressure monitoring

  18. Body composition [at 9 months]

    Assessment of whole body and abdominal fat mass, and total fat-free mass using DXA.

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Years to 16 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
List of inclusion criteria for Type 1 diabetes patients:
  1. disease for at least 1 year.
List of inclusion criteria for healthy subjects:
  1. good general health and normal growth.
List of exclusion Criteria for all subjects:
  1. presence of other chronic disease, including thyroid disease;

  2. medications, hormones other than insulin, or calcium preparations taken in the preceding 6 months;

  3. presence of nephropathy;

  4. systemic disease or hospitalization for more than 2 weeks in the preceding year;

  5. less than 6 menstrual cycles in the past year for post-menarche girls;

  6. participation in competitive sport.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital of Geneva Geneva Switzerland 1205

Sponsors and Collaborators

  • University Hospital, Geneva
  • Swiss National Science Foundation

Investigators

  • Principal Investigator: Farpour-Lambert Nathalie, PD, University Hospital, Geneva

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01220479
Other Study ID Numbers:
  • snf n°63164
First Posted:
Oct 14, 2010
Last Update Posted:
Oct 14, 2010
Last Verified:
Oct 1, 2010

Study Results

No Results Posted as of Oct 14, 2010